Retractable Technologies Book Value 2011-2026 | RVP

Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.

What is included in book value

Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.

Features of the metric

Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account.
Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market.
Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors.
Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.

Annual Book Value Retractable Technologies

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
87.2 M	99.3 M	107 M	99.2 M	49.9 M	28.5 M	25.6 M	27.2 M	28.1 M	31 M	26.8 M	28.9 M	35.7 M	38.7 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
107 M	25.6 M	50.9 M

Quarterly Book Value Retractable Technologies

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
76.8 M	76.5 M	76.6 M	87.2 M	83.5 M	85.4 M	99.7 M	99.3 M	99.4 M	104 M	107 M	107 M	109 M	102 M	105 M	99.2 M	79.6 M	74.6 M	67.8 M	49.9 M	49.9 M	49.9 M	49.9 M	28.5 M	28.5 M	28.5 M	28.5 M	25.6 M	25.6 M	25.6 M	25.6 M	27.2 M	27.2 M	27.2 M	27.2 M	28.1 M	28.1 M	28.1 M	28.1 M	30.8 M	31 M	31 M	31 M	26.8 M	26.8 M	26.8 M	26.8 M	28.9 M	28.9 M	28.9 M	28.9 M	35.7 M	35.7 M	35.7 M	35.7 M	38.7 M	38.7 M	38.7 M	38.7 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
109 M	25.6 M	51.2 M

Book Value of other stocks in the Medical instruments industry

Issuer	Book Value	Price	% 24h	Market Cap	Country
Atrion Corporation ATRI	243 K	-	-	$ 810 M	USA
Baxter International BAX	7.02 B	$ 20.66	1.27 %	$ 10.5 B	USA
Becton, Dickinson and Company BDX	55.3 B	$ 205.09	1.16 %	$ 59 B	USA
Luminex Corporation LMNX	199 M	-	-	$ 1.75 B	USA
Akers Biosciences, Inc. AKER	76.5 M	-	-9.52 %	$ 20.6 M	USA
Antares Pharma, Inc. ATRS	257 M	-	-	$ 955 M	USA
Cantel Medical Corp. CMD	411 M	-	-1.18 %	$ 3.4 B	USA
CRH Medical Corporation CRHM	762 M	-	-	$ 282 M	USA
Hill-Rom Holdings, Inc. HRC	388 M	-	-0.05 %	$ 10.3 B	USA
Ekso Bionics Holdings EKSO	12.7 M	$ 8.15	-7.6 %	$ 164 M	USA
Varian Medical Systems, Inc. VAR	66.7 M	-	-0.02 %	$ 16.3 B	USA
Alcon ALC	21.6 B	$ 80.67	-0.38 %	$ 40.4 B	Schweiz
AtriCure ATRC	461 M	$ 42.59	1.96 %	$ 2 B	USA
electroCore ECOR	7.44 M	$ 5.15	6.19 %	$ 28.4 K	USA
Haemonetics Corporation HAE	2.45 B	$ 84.98	2.36 %	$ 4.28 B	USA
AngioDynamics ANGO	183 M	$ 10.02	-8.29 %	$ 409 M	USA
Harvard Bioscience HBIO	73.1 M	$ 0.66	-1.92 %	$ 28 M	USA
The Cooper Companies COO	8.24 B	$ 83.38	-0.63 %	$ 16.6 B	USA
ICU Medical ICUI	4.2 B	$ 152.88	1.7 %	$ 3.73 B	USA
Glaukos Corporation GKOS	462 M	$ 114.49	0.43 %	$ 5.55 B	USA
InfuSystem Holdings INFU	48 M	$ 8.9	-0.11 %	$ 184 M	USA
iRhythm Technologies IRTC	90.9 M	$ 188.16	0.41 %	$ 5.87 B	USA
Isoray ISR	291 M	-	0.03 %	$ 108 M	USA
Repro Med Systems KRMD	20.4 M	$ 5.79	3.02 %	$ 264 M	USA
LeMaitre Vascular LMAT	337 M	$ 85.05	1.55 %	$ 1.91 B	USA
Masimo Corporation MASI	1.05 B	$ 138.18	0.8 %	$ 7.36 B	USA
Intuitive Surgical ISRG	16.5 B	$ 586.15	-1.03 %	$ 208 B	USA
Merit Medical Systems MMSI	1.38 B	$ 93.33	1.83 %	$ 5.43 B	USA
Microbot Medical MBOT	4.5 M	$ 2.19	3.55 %	$ 22.3 M	Israel
Nephros NEPH	8.36 M	$ 5.07	-1.74 %	$ 52.7 M	USA
Milestone Scientific MLSS	5.83 M	$ 0.29	2.24 %	$ 23.1 M	USA
NeuroMetrix NURO	14.3 M	-	5.05 %	$ 9.02 M	USA
Envista Holdings Corporation NVST	5.35 B	$ 23.52	2.53 %	$ 4.05 B	USA
OraSure Technologies OSUR	410 M	$ 2.65	5.38 %	$ 197 M	USA
Pro-Dex PDEX	36.6 M	$ 41.83	4.47 %	$ 138 M	USA
Predictive Oncology POAI	-203 K	$ 6.85	3.24 %	$ 37.4 M	USA
Pulse Biosciences PLSE	44.4 M	$ 14.71	-3.26 %	$ 707 M	USA
Repligen Corporation RGEN	1.96 B	$ 165.12	-2.32 %	$ 9.2 M	USA
ResMed RMD	3.36 B	$ 250.85	1.07 %	$ 36.6 B	USA
BioLife Solutions BLFS	349 M	$ 24.91	-1.97 %	$ 1.15 B	USA
STERIS plc STE	6.62 B	$ 260.64	0.52 %	$ 25.7 B	USA
Stereotaxis STXS	21.9 M	$ 2.57	-1.35 %	$ 207 M	USA
STAAR Surgical Company STAA	397 M	$ 22.43	1.08 %	$ 1.1 B	USA
Utah Medical Products UTMD	128 M	$ 58.5	1.39 %	$ 212 M	USA
Teleflex Incorporated TFX	4.28 B	$ 110.0	-13.07 %	$ 5.15 B	USA
West Pharmaceutical Services WST	2.68 B	$ 274.0	-1.62 %	$ 20 B	USA
DENTSPLY SIRONA XRAY	1.94 B	$ 12.53	1.25 %	$ 2.55 B	USA